Chiu, Hsiling
Celgene (United States)
2 papers on CoChatORCID 0000-0003-1390-0553
Most cited papers
- Verified
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
Bjorklund, C. C., Kang, J., Amatangelo, M., Polonskaia, A., Katz, M., Chiu, H., Couto, S., Wang, M., Ren, Y., Ortiz, M., et al. (2020) · Leukemia
Multiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors
Cited by 205
- Verified
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
Hagner, P. R., Man, H.-W., Fontanillo, C., Wang, M., Couto, S., Breider, M., Bjorklund, C., Havens, C. G., Lu, G., Rychak, E., et al. (2015) · Blood
Protein Degradation and InhibitorsLymphoma Diagnosis and Treatment
Cited by 203
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free